Sprint Bioscience AB Free Cash Flow Generation Index
Sprint Bioscience AB free cash flow generation index. Sprint Bioscience AB (SPRINT) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of Skr115.78 Million represents 1% of operating cash flow (Skr115.84 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Sprint Bioscience AB (2015–2025)
Free cash flow generation index of Sprint Bioscience AB from 2015 to 2025. Historical FCF Generation Index trend for Sprint Bioscience AB across 4 annual periods. See Sprint Bioscience AB (SPRINT) flexibility index to measure the company's free cash flow as a share of total liabilities.
Sprint Bioscience AB Free Cash Flow Generation Index by Year (2015–2025)
Sprint Bioscience AB free cash flow generation index by year from 2015 to 2025. Year-by-year Free Cash Flow Generation Index for Sprint Bioscience AB. For the full cash flow conversion analysis, see Sprint Bioscience AB cash flow conversion.
| Year | FCG Index | Free Cash Flow (SEK) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr83.44 Million | Skr83.53 Million | Skr94.00K | ▲ +11.9% |
| 2023 | 0.89x | Skr20.42 Million | Skr22.87 Million | Skr2.45 Million | ▲ +458.9% |
| 2016 | -0.25x | Skr-1.97 Million | Skr7.93 Million | Skr9.91 Million | ▲ +96.1% |
| 2015 | -6.43x | Skr-5.36 Million | Skr833.54K | Skr6.19 Million | — |